Asker, 1 July 2025: Reference is made to the stock exchange releases from Argeo ASA ("Argeo") published on 24 January 2025 and 31 March 2025. Argeo is pleased to announce that it, together with its ...

Reference is made to stock exchange notice of 1 March 2024, where Endúr ASA (“The Company”) announced its plan to buy up to 1,629,741 own shares for a total maximum NOK 50 million. In week 26 2025, ...

Key employees of Axactor ASA ("the Company") have on 1 July 2025 exercised 1,183,337 share options out of 1,650,004 vested share options under the long-term incentive program, ESOP2022. The Board of ...

Copenhagen, 1 July 2025: Cadeler A/S (“Cadeler”) has received notification pursuant to article 19 of the Market Abuse Regulation (EU) no. 596/2014 of the below transaction related to shares in Cadeler ...

About Publicis Groupe - The Power of One Publicis Groupe [Euronext Paris FR0000130577, CAC 40] is a global leader in communication. The Groupe is positioned at every step of the value chain, from ...

12-month readout of the HeROPA phase 2b clinical trial shows potential through key secondary endpoint PGA 0/1, where the per protocol population approaches significance (p = 0.07) after one year of ...

As a part of the share savings plan for employees in 2025, the following primary insiders have purchased Bakkafrost shares: · Regin Jacobsen, CEO, purchased 112 shares. After the transaction, he holds ...

GenSight Biologics (the " Company ") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal ...

Pryme Update: Oil Production and Outstanding Options Rotterdam, 1 July, 2025 In the second quarter of 2025, Pryme (the “Company”) produced approximately 150 metric tons of pyrolysis oil. The exact ...

Villers-lès-Nancy, 1 st July 2025 – 07:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2025 Number of shares ...

Oslo, 1 July 2025 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker "OBSVR") is pleased to announce the strengthening of its strategic partnership with its key manufacturing partner, ...

(1) In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all the shares to which voting rights are attached, including shares for which voting ...